Advertisement
Screener

INOZYME PHARMA, INC. Exchange Rate Effect on Cash

INOZYME PHARMA, INC. Exchange Rate Effect on Cash

INOZYME PHARMA, INC. reported Exchange Rate Effect on Cash of $2.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.

Financial Statements › Cash Flow › Change in Cash

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2025-05-14

  • INOZYME PHARMA, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2025-03-31 was $2.00K, a 80.00% decline year-over-year.
  • INOZYME PHARMA, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2024-03-31 was $10.00K, a 47.37% decline year-over-year.
  • INOZYME PHARMA, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2023-03-31 was $19.00K.
  • INOZYME PHARMA, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2022-03-31 was -$15.00K.
  • INOZYME PHARMA, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2024 was $4.00K.
  • INOZYME PHARMA, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2023 was -$18.00K.
  • INOZYME PHARMA, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2022 was -$25.00K, a 204.17% decline from fiscal 2021.
  • INOZYME PHARMA, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2021 was $24.00K.
Period endEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 3 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 6 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 9 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 12 month
2025-03-31$2.00K
10-Q · filed 2025-05-14
2024-12-31$4.00K
10-K · filed 2025-03-10
2024-09-30$8.00K
10-Q · filed 2024-11-05
2024-06-30$9.00K
10-Q · filed 2024-08-06
2024-03-31$10.00K
10-Q · filed 2025-05-14
2023-12-31-$18.00K
10-K · filed 2025-03-10
2023-09-30-$152.00K
10-Q · filed 2024-11-05
2023-06-30$30.00K
10-Q · filed 2024-08-06
2023-03-31$19.00K
10-Q · filed 2024-05-07
2022-12-31-$25.00K
10-K · filed 2024-03-12
2022-09-30-$78.00K
10-Q · filed 2023-11-07
2022-06-30-$58.00K
10-Q · filed 2023-08-08
2022-03-31-$15.00K
10-Q · filed 2023-05-09
2021-12-31$24.00K
10-K · filed 2023-03-22
2021-09-30-$9.00K
10-Q · filed 2022-11-10